Communicative aspects of decision aids for prostate cancer treatment: State of affairs, limitations, and recommendations

Ruben Vromans; Mies van Eenbergen; Steffen Pauws; Gijs Geleijnse; Henk van der Poel; L.V. van de Poll-Franse; Emiel Krahmer

Communicative aspects of decision aids for prostate cancer treatment: State of affairs, limitations, and recommendations

Ruben Vromans, Mies van Eenbergen, Steffen Pauws, Gijs Geleijnse, Henk van der Poel, L.V. van de Poll-Franse, Emiel Krahmer

Medical and Clinical Psychology

Research output: Contribution to conference › Paper › Other research output

Abstract

Despite increased interest in the development of decision aids (DAs) in prostate cancer care, little attention has been paid to communicative aspects of such tools. In this systematic review, we identified nineteen DAs for localized prostate cancer treatment through both published literature (MEDLINE, Embase, CINAHL, CENTRAL, and PsycINFO; 1990-2018) and online sources, and reviewed them for International Patient Decision Aids Standards (IPDAS) criteria and various communicative aspects. Results revealed variations in the use of IPDAS criteria and communicative aspects by DAs: (1) Few used visual aids to present (statistical) information, (2) none communicated personalized outcome probabilities, (3) a minority used interactive methods to elicit patients’ values and preferences, and (4) most included biased side-by-side displays to compare treatment options. These issues may encourage communication researchers to develop intervention strategies for improving communicative aspects of DAs, which may lead to increased patient participation and understanding of treatments during shared decision making.

Original language	English
Publication status	Published - 2019
Event	Annual Conference of the International Communication Association 2019: Communication Beyond Boundaries - Washington, United States Duration: 24 May 2019 → 28 May 2019 Conference number: 69 https://www.icahdq.org/page/2019Conference

Conference

Conference	Annual Conference of the International Communication Association 2019
Abbreviated title	ICA 2019
Country/Territory	United States
City	Washington
Period	24/05/19 → 28/05/19
Internet address	https://www.icahdq.org/page/2019Conference

Keywords

Decision aids
Shared decision-making
Prostate cancer
Risk communication
Health communication
Patient Education as Topic
Decision support system
Communicative aspects
Treatment

Cite this

@conference{d1c8052003f24efc9850ea6f8b1280a8,

title = "Communicative aspects of decision aids for prostate cancer treatment: State of affairs, limitations, and recommendations",

abstract = "Despite increased interest in the development of decision aids (DAs) in prostate cancer care, little attention has been paid to communicative aspects of such tools. In this systematic review, we identified nineteen DAs for localized prostate cancer treatment through both published literature (MEDLINE, Embase, CINAHL, CENTRAL, and PsycINFO; 1990-2018) and online sources, and reviewed them for International Patient Decision Aids Standards (IPDAS) criteria and various communicative aspects. Results revealed variations in the use of IPDAS criteria and communicative aspects by DAs: (1) Few used visual aids to present (statistical) information, (2) none communicated personalized outcome probabilities, (3) a minority used interactive methods to elicit patients{\textquoteright} values and preferences, and (4) most included biased side-by-side displays to compare treatment options. These issues may encourage communication researchers to develop intervention strategies for improving communicative aspects of DAs, which may lead to increased patient participation and understanding of treatments during shared decision making.",

keywords = "Decision aids, Shared decision-making, Prostate cancer, Risk communication, Health communication, Patient Education as Topic, Decision support system, Communicative aspects, Treatment",

author = "Ruben Vromans and {van Eenbergen}, Mies and Steffen Pauws and Gijs Geleijnse and {van der Poel}, Henk and {van de Poll-Franse}, L.V. and Emiel Krahmer",

year = "2019",

language = "English",

note = "Annual Conference of the International Communication Association 2019 : Communication Beyond Boundaries, ICA 2019 ; Conference date: 24-05-2019 Through 28-05-2019",

url = "https://www.icahdq.org/page/2019Conference",

}

Vromans, R, van Eenbergen, M, Pauws, S, Geleijnse, G, van der Poel, H, van de Poll-Franse, LV & Krahmer, E 2019, 'Communicative aspects of decision aids for prostate cancer treatment: State of affairs, limitations, and recommendations', Paper presented at Annual Conference of the International Communication Association 2019, Washington, United States, 24/05/19 - 28/05/19.

Communicative aspects of decision aids for prostate cancer treatment: State of affairs, limitations, and recommendations. / Vromans, Ruben; van Eenbergen, Mies; Pauws, Steffen et al.
2019. Paper presented at Annual Conference of the International Communication Association 2019, Washington, United States.

Research output: Contribution to conference › Paper › Other research output

TY - CONF

T1 - Communicative aspects of decision aids for prostate cancer treatment: State of affairs, limitations, and recommendations

AU - Vromans, Ruben

AU - van Eenbergen, Mies

AU - Pauws, Steffen

AU - Geleijnse, Gijs

AU - van der Poel, Henk

AU - van de Poll-Franse, L.V.

AU - Krahmer, Emiel

N1 - Conference code: 69

PY - 2019

Y1 - 2019

N2 - Despite increased interest in the development of decision aids (DAs) in prostate cancer care, little attention has been paid to communicative aspects of such tools. In this systematic review, we identified nineteen DAs for localized prostate cancer treatment through both published literature (MEDLINE, Embase, CINAHL, CENTRAL, and PsycINFO; 1990-2018) and online sources, and reviewed them for International Patient Decision Aids Standards (IPDAS) criteria and various communicative aspects. Results revealed variations in the use of IPDAS criteria and communicative aspects by DAs: (1) Few used visual aids to present (statistical) information, (2) none communicated personalized outcome probabilities, (3) a minority used interactive methods to elicit patients’ values and preferences, and (4) most included biased side-by-side displays to compare treatment options. These issues may encourage communication researchers to develop intervention strategies for improving communicative aspects of DAs, which may lead to increased patient participation and understanding of treatments during shared decision making.

AB - Despite increased interest in the development of decision aids (DAs) in prostate cancer care, little attention has been paid to communicative aspects of such tools. In this systematic review, we identified nineteen DAs for localized prostate cancer treatment through both published literature (MEDLINE, Embase, CINAHL, CENTRAL, and PsycINFO; 1990-2018) and online sources, and reviewed them for International Patient Decision Aids Standards (IPDAS) criteria and various communicative aspects. Results revealed variations in the use of IPDAS criteria and communicative aspects by DAs: (1) Few used visual aids to present (statistical) information, (2) none communicated personalized outcome probabilities, (3) a minority used interactive methods to elicit patients’ values and preferences, and (4) most included biased side-by-side displays to compare treatment options. These issues may encourage communication researchers to develop intervention strategies for improving communicative aspects of DAs, which may lead to increased patient participation and understanding of treatments during shared decision making.

KW - Decision aids

KW - Shared decision-making

KW - Prostate cancer

KW - Risk communication

KW - Health communication

KW - Patient Education as Topic

KW - Decision support system

KW - Communicative aspects

KW - Treatment

M3 - Paper

T2 - Annual Conference of the International Communication Association 2019

Y2 - 24 May 2019 through 28 May 2019

ER -

Communicative aspects of decision aids for prostate cancer treatment: State of affairs, limitations, and recommendations

Abstract

Conference

Keywords

Fingerprint

Cite this